Partnering & Collaborations

Our vision is to create innovative oncology products.

Cellectar is looking to collaborate with partners having interest in utilizing our proprietary PDC Delivery Platform for targeted delivery of oncologic payloads that results in improved therapeutic indices. Cellectar’s business development strategy is to balance internal research and product development with academic collaboration and corporate partnering to advance its PDC Delivery Platform and promising pipeline of oncology product candidates while optimizing internal resources and shareholder value.



Cellectar‘s goal is to improve the lives of cancer patients through innovation, collaboration,
and the manufacturing of our targeted drug delivery technologies.